MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    Reduced plasma levels of various cell signaling molecules in patients with Parkinson’s Disease

    S. Zadegan, A. Teixeira, E. Furr Stimming, N. Pessoa Rocha (Housotn, USA)

    Objective: To define the profile of different cell signaling molecules in the blood of patients with Parkinson’s Disease (PD) compared to controls. Background: PD is…
  • 2024 International Congress

    Dynamic video-assessment of axial postural abnormalities in parkinsonism: feasibility and pilot analysis

    C. Geroin, C. Artusi, S. Camozzi, G. Imbalzano, S. Aldegheri, L. Lopiano, N. Bombieri, M. Tinazzi (Verona, Italy)

    Objective: To evaluate changes in the degree of axial postural abnormalities (APAs) using the AutoPosturePD software during standing and walking under single/dual-task conditions. Background: We…
  • 2024 International Congress

    Engage, Educate and Empower: Parkinson’s Research Advocates from the Black and African American Community

    R. Mills-Joseph, K. Gamble, T. Best, K. Williams, L. Wilson, D. Coley, B. Coley, M. Fitts, R. Huckabee, A. Huckabee, E. Lewis, L. Seghetti, C. Branson, H. Shah, A. Kumeh, C. Gallagher, C. Evers, E. Stevens (Columbus, USA)

    Objective: To assess engagement in research advocacy among Black and African people with Parkinson’s and their care partners. Background: Black and African American people with…
  • 2024 International Congress

    The Pro-LBD Study Investigating Early Detection, Prognosis, and Biomarkers of Prodromal Lewy Body Diseases

    J. Maple-Grødem, V. Frantzen, J. Lange, E. Fiske, E. Bjordal, V. Forsaa, ø. Kallevåg, J. Berge, A. Jimenez, P. Førland, D. Aarsland, G. Alves (Stavanger, Norway)

    Objective: The Pro-LBD cohort study is a prospective, long-term, clinic-biological cohort study of participants who are stratified by their risk of developing a Lewy body…
  • 2024 International Congress

    Association between use of Furosemide and Risk of Parkinson’s disease

    B. Babar, AM. Tolppanen, S. Hartikainen, M. Tiihonen (Kuopio, Finland)

    Objective: Main objective of study is to check the association between furosemide use and risk of Parkinson's disease (PD) in a Finnish nationwide nested case-control…
  • 2024 International Congress

    MDS Clinical Supportive Criteria for Parkinson’s Disease are Associated with α-Synuclein Seed Amplification Assay Status

    D. Belete, E. Mitchell, N. Donkor, A. Noyce, C. Simonet (London, United Kingdom)

    Objective: To assess the association between α-synuclein seed amplification assay (α-synuclein SAA) status with the supportive criteria of the MDS Clinical Diagnostic Criteria for Parkinson’s…
  • 2024 International Congress

    Pallidotomy as a Therapeutic Option for Patients with Advanced Parkinson’s Disease: Case Study

    R. Pessoa, L. Cidral, E. de Souza, M. Marchiori (Curitiba, Brazil)

    Objective: The aim of this research is to assess unilateral pallidotomy as a surgical alternative for Parkinson's Disease (PD), emphasizing improvements in contralateral motor symptoms…
  • 2024 International Congress

    Mitigating The Impact Of Covid-19 On Parkinson’s Disease: Insights From Vaccination Strategies

    J. Salimjonov, KH. Khalimova, N. Rashidova, R. Matmurodov (Tashkent, Uzbekistan)

    Objective: This study aimed to investigate the impact of COVID-19 infection on patients with Parkinson's disease (PD), comparing those who received COVID-19 vaccines and those…
  • 2024 International Congress

    Subthalamic Nucleus Stimulation Modulates Cognitive Theory of Mind in Parkinson’s Disease

    HY. Xiao, LQ. Lang, Z. Ye, JJ. Wu (Shanghai, China)

    Objective: This study aims to investigate the effect of subthalamic nucleus (STN) deep brain stimulation (DBS) on ToM using the Parkinson’s disease (PD) model. Background:…
  • 2024 International Congress

    Misdiagnosis of Cognitive Impairment in Parkinson’s disease

    F. Rodriguez-Porcel, T. Turner (Charleston, USA)

    Objective: We explored potential bias to diagnose cognitive impairment in People with Parkinson’s (PwP) followed in the Parkinson’s Progressive Markers Initiative (PPMI). Background: In primary…
  • « Previous Page
  • 1
  • …
  • 178
  • 179
  • 180
  • 181
  • 182
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • #24475 (not found)
  • #24187 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley